Zurich Cantonal Bank’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-15,690
| Closed | -$49K | – | 2674 |
|
2020
Q3 | $49K | Hold |
15,690
| – | – | ﹤0.01% | 2265 |
|
2020
Q2 | $46K | Hold |
15,690
| – | – | ﹤0.01% | 2237 |
|
2020
Q1 | $44K | Buy |
15,690
+6,528
| +71% | +$18.3K | ﹤0.01% | 2003 |
|
2019
Q4 | $30K | Hold |
9,162
| – | – | ﹤0.01% | 2391 |
|
2019
Q3 | $20K | Hold |
9,162
| – | – | ﹤0.01% | 2463 |
|
2019
Q2 | $29K | Hold |
9,162
| – | – | ﹤0.01% | 2343 |
|
2019
Q1 | $34K | Hold |
9,162
| – | – | ﹤0.01% | 2220 |
|
2018
Q4 | $27K | Hold |
9,162
| – | – | ﹤0.01% | 2355 |
|
2018
Q3 | $24K | Hold |
9,162
| – | – | ﹤0.01% | 2450 |
|
2018
Q2 | $21K | Hold |
9,162
| – | – | ﹤0.01% | 2428 |
|
2018
Q1 | $27K | Hold |
9,162
| – | – | ﹤0.01% | 2338 |
|
2017
Q4 | $25K | Hold |
9,162
| – | – | ﹤0.01% | 2347 |
|
2017
Q3 | $31K | Buy |
9,162
+4,640
| +103% | +$15.7K | ﹤0.01% | 2101 |
|
2017
Q2 | $11K | Sell |
4,522
-41,426
| -90% | -$101K | ﹤0.01% | 2418 |
|
2017
Q1 | $104K | Buy |
45,948
+14,000
| +44% | +$31.7K | ﹤0.01% | 1334 |
|
2016
Q4 | $68K | Sell |
31,948
-700
| -2% | -$1.49K | ﹤0.01% | 1535 |
|
2016
Q3 | $109K | Buy |
32,648
+16,821
| +106% | +$56.2K | ﹤0.01% | 1216 |
|
2016
Q2 | $50K | Buy |
15,827
+11,305
| +250% | +$35.7K | ﹤0.01% | 1498 |
|
2016
Q1 | $15K | Hold |
4,522
| – | – | ﹤0.01% | 2233 |
|
2015
Q4 | $16K | Buy |
4,522
+2,763
| +157% | +$9.78K | ﹤0.01% | 2235 |
|
2015
Q3 | $9K | Buy |
1,759
+1,055
| +150% | +$5.4K | ﹤0.01% | 2182 |
|
2015
Q2 | $5K | Hold |
704
| – | – | ﹤0.01% | 2020 |
|
2015
Q1 | $5K | Buy |
+704
| New | +$5K | ﹤0.01% | 2009 |
|
2013
Q4 | – | Sell |
-27,778
| Closed | -$221K | – | 1023 |
|
2013
Q3 | $221K | Buy |
+27,778
| New | +$221K | 0.01% | 806 |
|